Company Description
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is h...
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
Valuation
Price to Sales Ratio
2.42
Price to Book Ratio
7.85
Enterprise Value to Sales
2.07
Total Debt to Enterprise Value
0.03
Efficiency
Revenue/Employee
205,026.00
Income Per Employee
-114,141.00
Receivables Turnover
10.61
Total Asset Turnover
1.27
Liquidity
Current Ratio
2.98
Quick Ratio
2.69
Cash Ratio
2.10
Profitability
Gross Margin
4.63
Operating Margin
-55.62
Pretax Margin
-55.67
Net Margin
-55.67
Return on Assets
-70.46
Return on Equity
-143.41
Return on Total Capital
-132.07
Return on Invested Capital
-138.23
Capital Structure
Total Debt to Total Equity
19.87
Total Debt to Total Capital
16.58
Total Debt to Total Assets
9.11
Long-Term Debt to Equity
8.76
Long-Term Debt to Total Capital
7.31
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. John Peter McLaughlin | 67 | 2019 | Director |
Dr. Russell H. Ellison | 71 | 2020 | Director |
Mr. Michael DeYoung | - | 2018 | Vice President-Operations |
Mr. Russell L. Skibsted | 60 | 2020 | Executive VP, Chief Financial & Business Officer |
Dr. Marc Hoffman | 58 | 2019 | Chief Medical Officer |
Insider Actions
12/21/2020 |
Richmond Brothers, Inc. |
42,450 | Disposition at $1.03 per share. | 43,723 |
12/16/2020 |
Richmond Brothers, Inc. |
100,000 | Disposition at $1.02 per share. | 102,000 |
12/16/2020 |
Richmond Brothers, Inc. |
100,000 | Disposition at $1.02 per share. | 102,000 |
12/16/2020 |
Richmond Brothers, Inc. |
136,021 | Disposition at $1.01 per share. | 137,381 |
12/16/2020 |
Richmond Brothers, Inc. |
185,855 | Disposition at $1.01 per share. | 187,713 |
12/15/2020 |
Richmond Brothers, Inc. |
43,979 | Disposition at $1.1 per share. | 48,376 |
12/15/2020 |
Richmond Brothers, Inc. |
234,145 | Disposition at $1.11 per share. | 259,900 |
12/11/2020 |
Allen R. Nissenson Director |
1,488 | Award at $0 per share. | 0 |
12/11/2020 |
Andrea Heslin Smiley Director |
18,601 | Award at $1.12 per share. | 20,833 |
12/07/2020 |
Mark H. Ravich Director |
219,905 | 268,284 | |
12/07/2020 |
Mark H. Ravich Director |
219,905 | 268,284 | |
09/04/2020 |
Mark H. Ravich Director |
25,000 | 30,500 | |
09/04/2020 |
Mark H. Ravich Director |
9,000 | 10,440 | |
09/04/2020 |
Mark H. Ravich Director |
16,000 | 18,560 | |
09/04/2020 |
Mark H. Ravich Director |
10,000 | 11,600 | |
09/03/2020 |
Mark H. Ravich Director |
194,905 | 237,784 | |
09/03/2020 |
Mark H. Ravich Director |
11,000 | 13,310 | |
09/03/2020 |
Mark H. Ravich Director |
173,905 | 210,425 | |
06/30/2020 |
Richmond Brothers, Inc. |
7,526 | Acquisition at $1.92 per share. | 14,449 |
06/30/2020 |
Richmond Brothers, Inc. |
9,946 | Acquisition at $1.92 per share. | 19,096 |
06/30/2020 |
Richmond Brothers, Inc. |
650 | Acquisition at $1.94 per share. | 1,261 |
06/30/2020 |
Richmond Brothers, Inc. |
9 | Acquisition at $1.95 per share. | 17 |
06/30/2020 |
Richmond Brothers, Inc. |
1,682 | Acquisition at $1.94 per share. | 3,263 |
06/30/2020 |
Richmond Brothers, Inc. |
3,156 | Acquisition at $1.95 per share. | 6,154 |
06/30/2020 |
Richmond Brothers, Inc. |
1,712 | Acquisition at $1.94 per share. | 3,321 |
06/11/2020 |
Allen R. Nissenson Director |
23,000 | Award at $0 per share. | 0 |
05/18/2020 |
Mark H. Ravich Director |
30,800 | Award at $0 per share. | 0 |
05/18/2020 |
John Peter McLaughlin Director |
51,800 | Award at $0 per share. | 0 |
05/18/2020 |
John G. Cooper Director |
36,000 | Award at $0 per share. | 0 |
05/18/2020 |
Robert Samuel Radie Director |
31,000 | Award at $0 per share. | 0 |
MarketWatch News on RMTI
-
Carl Icahn Opposes Deal as Proposed by Michael Dell
- Barron's Online
-
Blackwell Likes Supervalu Retail and Wholesale
- Barron's Online
-
Elliott Associates Sees Growth in Gigamon
- Barron's Online
-
Investor Wants Rockwell Medical to Go High-Margin
- Barron's Online
-
ValueAct Affirms Its Investment in Valeant
- Barron's Online
-
Blue Harbour Group Has Bought Into WebMD
- Barron's Online
-
Starboard Value Likes What It Sees in Tribune Media
- Barron's Online
-
Rockwell Medical downgraded to hold from buy at Stifel Nicolaus
- Tomi Kilgore
-
Three health-care deals today are paying huge premiums
- Philip van Doorn
-
10 Undervalued Stocks Insiders Are Buying
- Barron's Online
-
10 cheapest stocks in the Nasdaq’s hottest sector
- Philip van Doorn
-
- Barron's Online
-
- Barron's Online
-
- Barron's Online
-
7 Stock Picks From an Insider Trading Guru
- Barron's Online
-
3 best hedge fund managers of 2013
- Insider Monkey
-
- Barron's Online
-
6 gut checks before the stock market's opening bell
- Shawn Langlois
- Loading more headlines...
Other News on RMTI
-
Rockwell Medical: Heavily Oversold Company With Big Potential
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Rockwell Medical EPS in-line, misses on revenue
- Seeking Alpha
-
JKS, DQ, ACB and LAC among midday movers
- Seeking Alpha
-
Rockwell Medical announces $35M direct offering
- Seeking Alpha
-
GME, CVNA, WPRT and SOL among midday movers
- Seeking Alpha
-
GME, CVNA among premarket gainers
- Seeking Alpha
-
- Zacks.com
-
RH, SLQT among premarket gainers
- Seeking Alpha
-
Rockwell Medical gains 15% on Triferic pact in South Korea
- Seeking Alpha
- Loading more headlines...